CardioGenesis Laser Therapies for Angina and Heart Disease Patients Q3 02 Results Final Page 5
CARDIOGENESIS REPORTS THIRD QUARTER, NINE-MONTH RESULTS
Page 5-5-5
# # # #
CARDIOGENESIS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
September 30,
December 31,
2002 2001
ASSETS
Cash and cash equivalents
$ 1,801 $ 2,629
Accounts receivable, net
1,876
2,330
Inventories
2,083
3,215
Property and equipment, net
655
863
Other assets
2,323
2,272
Total assets
$ 8,738 $ 11,309
LIABILITIES AND SHAREHOLDERS' EQUITY
Accounts payable and accrued liabilities
$ 4,681
$ 6,796
Deferred revenue
602
931
Shareholders' equity
3,455
3,582
Total liabilities and shareholders' equity
$ 8,738 $ 11,309
